GO:0009615 response to virus: Genes and Research

GO:0009615, response to virus, is a Gene Ontology biological process term that describes any process resulting in a change in state or activity of a cell or an organism as a result of a stimulus from a virus. This includes changes in movement, secretion, enzyme production, gene expression and other cellular activities triggered by viral exposure. The term captures the full spectrum of host reactions, from initial sensing of viral components to the activation of antiviral effector programs and the resolution or persistence of infection. Understanding response to virus is fundamental for virology, immunology and the development of antiviral therapies and vaccines [2,8]. The response to virus is not a single linear pathway but a coordinated network of sensing, signaling and effector mechanisms. For influenza virus, innate immune responses in the upper respiratory tract involve epithelial cells, macrophages and dendritic cells that detect viral RNA and produce interferons and pro-inflammatory cytokines [2,6]. Similar principles apply to other RNA and DNA viruses, although the specific sensors and effectors can differ [3,4,5]. For example, Zika virus and dengue virus elicit overlapping but distinct host responses that influence pathogenesis and disease outcomes [3,4]. Because the response to virus is genetically encoded and highly dynamic, it is a prime target for functional genomics. CRISPR-based approaches allow researchers to knock out, mutate, knock in or overexpress candidate genes and then measure how these perturbations alter viral replication, interferon signaling or cell survival [1,2]. Such studies are essential for identifying host dependency factors and restriction factors, and for understanding how viruses such as influenza A virus, SARS-CoV-2, Zika virus, dengue virus and African swine fever virus interact with their hosts [3,4,5,7].

According to the Gene Ontology, GO:0009615 response to virus is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus. In simpler terms, it is the collection of all host reactions triggered by a virus, ranging from immediate sensing and signaling events to long-term changes in gene expression and cellular behavior. The synonym response to viruses is also used. This term is a biological process and is distinct from viral processes themselves; it specifically describes the host's response to the virus.

The response to virus is a central determinant of infection outcome, influencing viral clearance, tissue damage and disease severity. It is also a major source of host-directed antiviral targets and biomarkers. Because viruses continually evolve mechanisms to evade or subvert host responses, understanding this process at the molecular level is essential for developing broad-spectrum antivirals and effective vaccines [2,8]. Moreover, dysregulated responses can cause immunopathology, as seen in severe influenza and other viral infections.

The following genes and proteins are central to the response to virus, based on published literature on influenza, Zika, dengue, African swine fever and related viruses.

The response to virus is tightly regulated at multiple levels. Interferon signaling is controlled by negative feedback loops, including SOCS proteins and phosphatases, to prevent excessive inflammation. Viral proteins can also regulate the response by degrading or inhibiting key signaling molecules. In influenza virus infection, the balance between pro-inflammatory and anti-inflammatory signals influences disease outcome. Coinfection with influenza A virus and SARS-CoV-2 can modulate the host response, demonstrating that external factors can regulate this process. Additionally, host genetic variation in genes such as OAS1, MX1 and IFITM3 can affect the strength of the response [2,4].

The response to influenza virus is a major determinant of disease severity. Innate immune responses in the upper respiratory tract, including interferon production and macrophage activation, can control viral replication but also contribute to lung inflammation [2,6]. Excessive cytokine production, sometimes called a cytokine storm, is associated with severe influenza and poor outcomes. Understanding these mechanisms is critical for developing treatments that balance antiviral defense and immunopathology.

Zika virus and dengue virus elicit host responses that can be protective or pathogenic. Zika virus infection during pregnancy can cause congenital abnormalities, and the host response influences neurotropism and tissue damage. Dengue virus infection can lead to severe dengue, where an overactive immune response contributes to plasma leakage and shock. Studying the response to these viruses helps identify targets for antiviral therapy and vaccines.

African swine fever virus causes a lethal hemorrhagic disease in pigs, with no widely available vaccine. The host response to this virus is complex and involves evasion of innate immunity. Understanding these interactions is essential for developing control measures and vaccines for this economically important pathogen.

Coinfections can alter the response to virus in unpredictable ways. Influenza A virus infection has been shown to interfere with SARS-CoV-2 replication during coinfection, suggesting that the host response to one virus can modulate another. Such interactions are important for clinical management during seasonal and pandemic outbreaks.

RNA sequencing is widely used to profile gene expression changes during response to virus. It can reveal interferon-stimulated genes, inflammatory pathways and viral transcripts. For example, transcriptomic studies of influenza virus infection have identified key innate immune signatures. RNA-seq can be applied to knockout or overexpression models to determine how specific genes shape the response.

Mass spectrometry-based proteomics can identify host and viral proteins that interact during infection. This is particularly useful for mapping how viral proteins antagonize host defenses, as seen with African swine fever virus. Affinity purification of tagged viral proteins from infected cells can reveal host targets and pathways.

Genome-wide CRISPR knockout or activation screens enable unbiased discovery of host genes that promote or restrict viral replication. These screens have been used to identify dependency factors for influenza, Zika and other viruses. Hits from screens can be validated with individual knockout or overexpression models.

Fluorescence microscopy and luciferase reporter assays are used to visualize viral replication and interferon signaling in real time. Reporter cell lines expressing interferon-driven luciferase can quantify the response to virus in high-throughput formats. Imaging of infected cells can reveal subcellular localization of viral and host proteins.

Researchers studying response to virus-related genes often need to determine whether a candidate gene is causally involved in antiviral defense or viral replication. This requires precise genetic models that can knock out, mutate, knock in or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.

GO:0009615 response to virus is a fundamental biological process that encompasses the full range of host reactions to viral infection, from sensing and signaling to effector mechanisms and immune evasion. It is central to understanding viral pathogenesis and to developing antiviral therapies and vaccines. Advances in CRISPR-based functional genomics, combined with transcriptomics and proteomics, are rapidly expanding our knowledge of the host genes that control this process [1,2]. EDITGENE offers comprehensive CRISPR services to support researchers in dissecting the response to virus and translating these insights into clinical applications.